Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach
- PMID: 38280624
- PMCID: PMC11272903
- DOI: 10.1016/j.hrthm.2024.01.031
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach
Abstract
Background: Patients with hypertrophic cardiomyopathy (HCM) are at risk of sudden death, and individuals with ≥1 major risk markers are considered for primary prevention implantable cardioverter-defibrillators. Guidelines recommend cardiac magnetic resonance (CMR) imaging to identify high-risk imaging features. However, CMR imaging is resource intensive and is not widely accessible worldwide.
Objective: The purpose of this study was to develop electrocardiogram (ECG) deep-learning (DL) models for the identification of patients with HCM and high-risk imaging features.
Methods: Patients with HCM evaluated at Tufts Medical Center (N = 1930; Boston, MA) were used to develop ECG-DL models for the prediction of high-risk imaging features: systolic dysfunction, massive hypertrophy (≥30 mm), apical aneurysm, and extensive late gadolinium enhancement. ECG-DL models were externally validated in a cohort of patients with HCM from the Amrita Hospital HCM Center (N = 233; Kochi, India).
Results: ECG-DL models reliably identified high-risk features (systolic dysfunction, massive hypertrophy, apical aneurysm, and extensive late gadolinium enhancement) during holdout testing (c-statistic 0.72, 0.83, 0.93, and 0.76) and external validation (c-statistic 0.71, 0.76, 0.91, and 0.68). A hypothetical screening strategy using echocardiography combined with ECG-DL-guided selective CMR use demonstrated a sensitivity of 97% for identifying patients with high-risk features while reducing the number of recommended CMRs by 61%. The negative predictive value with this screening strategy for the absence of high-risk features in patients without ECG-DL recommendation for CMR was 99.5%.
Conclusion: In HCM, novel ECG-DL models reliably identified patients with high-risk imaging features while offering the potential to reduce CMR testing requirements in underresourced areas.
Keywords: Cardiac magnetic resonance imaging; Deep-learning; Electrocardiography; Hypertrophic cardiomyopathy; Risk prediction; Sudden cardiac death.
Copyright © 2024 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures Dr Maron is a consultant for Cytokinetics, iRhythm, Imbria Pharmaceuticals, and Takeda Pharmaceuticals. Dr Rowin has received research funding from Pfizer and iRhythm. The remaining authors have nothing to disclose.
Figures


Comment in
-
Electrocardiography deep learning models to predict high-risk imaging features in patients with hypertrophic cardiomyopathy: Can it change clinical practice?Heart Rhythm. 2024 Aug;21(8):1398-1399. doi: 10.1016/j.hrthm.2024.02.023. Epub 2024 Feb 15. Heart Rhythm. 2024. PMID: 38365126 No abstract available.
Similar articles
-
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy.Am Heart J. 2025 Nov;289:28-37. doi: 10.1016/j.ahj.2025.04.030. Epub 2025 May 3. Am Heart J. 2025. PMID: 40324572
-
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.JACC Cardiovasc Imaging. 2012 Apr;5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021. JACC Cardiovasc Imaging. 2012. PMID: 22498326
-
Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.Int J Cardiol. 2025 Feb 15;421:132911. doi: 10.1016/j.ijcard.2024.132911. Epub 2024 Dec 18. Int J Cardiol. 2025. PMID: 39706305
-
Artificial intelligence-driven electrocardiography: Innovations in hypertrophic cardiomyopathy management.Trends Cardiovasc Med. 2025 Feb;35(2):126-134. doi: 10.1016/j.tcm.2024.08.002. Epub 2024 Aug 13. Trends Cardiovasc Med. 2025. PMID: 39147002 Review.
-
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy.JACC Heart Fail. 2025 Jun;13(6):1014-1026. doi: 10.1016/j.jchf.2024.12.006. Epub 2025 Mar 12. JACC Heart Fail. 2025. PMID: 40088231
Cited by
-
Electrocardiographic Risk Stratification in Critically Ill Cardiac Patients: Can Deep Learning Fulfill its Promise?JACC Adv. 2024 Aug 21;3(9):101168. doi: 10.1016/j.jacadv.2024.101168. eCollection 2024 Sep. JACC Adv. 2024. PMID: 39372472 Free PMC article.
-
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques.J Cardiovasc Dev Dis. 2025 Mar 14;12(3):101. doi: 10.3390/jcdd12030101. J Cardiovasc Dev Dis. 2025. PMID: 40137099 Free PMC article. Review.
-
Improved diagnosis of arrhythmogenic right ventricular cardiomyopathy using electrocardiographic deep learning.Heart Rhythm. 2025 Apr;22(4):1080-1088. doi: 10.1016/j.hrthm.2024.08.030. Epub 2024 Aug 20. Heart Rhythm. 2025. PMID: 39168295
-
The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.Curr Cardiol Rep. 2025 Jun 20;27(1):98. doi: 10.1007/s11886-025-02250-7. Curr Cardiol Rep. 2025. PMID: 40540063 Review.
-
Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy.Quant Imaging Med Surg. 2025 Apr 1;15(4):2905-2916. doi: 10.21037/qims-24-1638. Epub 2025 Mar 28. Quant Imaging Med Surg. 2025. PMID: 40235757 Free PMC article.
References
-
- Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015;65:1249–1254. - PubMed
-
- Maron BJ, Rowin EJ, Casey SA, Maron MS. How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice. JAMA Cardiol 2016;1:98–105. - PubMed
-
- Ommen SR, Mital S, Burke MA et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020;142:e533–e557. - PubMed
-
- Rowin EJ, Maron BJ, Haas TS et al. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. J Am Coll Cardiol 2017;69:761–773. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources